![Genenta Science S.p.A. logo](/logos/GNTA.webp)
Genenta Science S.p.A.
NASDAQ:GNTA
Overview | Financials
Company Name | Genenta Science S.p.A. |
Symbol | GNTA |
Currency | USD |
Price | 4.135 |
Market Cap | 75,327,121 |
Dividend Yield | 0% |
52-week-range | 2.2 - 5.89 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Pierluigi Paracchi |
Website | https://www.genenta.com |
An error occurred while fetching data.
About Genenta Science S.p.A.
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD